Biomarkers for Oncology
JH · Effective Oct 1, 2015
31 active Medicare policies list 81540, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Jul 17, 2023
JH · Effective Jul 17, 2023
JL · Effective Jul 17, 2023
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
6 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 81540 |
|---|---|---|
| Gene Expression Profiling for Cancer Indications | May 1, 2026 | Covered with conditions |
| Gene Expression Profiling for Cancer Indications | Apr 8, 2026 | Covered |
| Policy | Effective | Status of 81540 |
|---|---|---|
| Tumor Markers | Mar 5, 2024 | Covered |
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
J9 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JL · Effective Apr 24, 2025
National · Effective Oct 1, 2024
National · Effective Oct 1, 2024
National · Effective Feb 19, 2026
J5 · Effective Aug 27, 2026
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
J5 · Effective Jul 1, 2026
JL · Effective Jul 1, 2026
J9 · Effective Jul 1, 2026
J6 · Effective Jul 15, 2026
| Policy | Effective | Status of 81540 |
|---|
| Concert Genetic Testing Oncology: Algorithmic Assays | Not recorded | Referenced |
|---|
| Policy | Effective | Status of 81540 |
|---|---|---|
| Predictive and Prognostic Polygenic Testing | Jun 14, 2026 | Covered |
| Policy | Effective | Status of 81540 |
|---|---|---|
| Gene Expression-Based Assays for Cancers of Unknown Primary | Jun 1, 2026 | Covered |